SCIENTIFIC HUB

Follow the evidence.

15.361 articles found

Open access

Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson's disease and monogenic dystonia: a multidisciplinary team perspective.

Rački V, Hero M, Papić E, Rožmarić G, Čizmarević NS, Chudy D, Peterlin B, Vuletić V.

Front Neurosci · 2023-11-10

DOI: 10.3389/fnins.2023.1282267PMID: 38027472

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Feasibility of home dose optimization of apomorphine sublingual film in Parkinson's disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study.

Kassubek J, Stocchi F, Martinez EB, Pahwa R, Ondo W, Zhang Y, Bowling A, Pappert E, Isaacson S, Wu S, CTH-302 Study Investigators*.

Ther Adv Neurol Disord · 2023-11-09

DOI: 10.1177/17562864231209240PMID: 37954918

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Evidence of Brain Target Engagement in Parkinson’s Disease and Multiple Sclerosis by the Investigational Nanomedicine, CNM-Au8, in the REPAIR Phase 2 Clinical Trials

Ren J, Dewey IRB, Rynders A, Evan J, Evan J, Ligozio S, Ho KS, Sguigna PV, Glanzman R, Hotchkin MT, Dewey RB, Greenberg BM.

· 2023-11-07

DOI: 10.21203/rs.3.rs-3554427/v1

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.